BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18782859)

  • 1. Evidence behind the WHO guidelines: Hospital Care for Children: the usefulness of azole prophylaxis against cryptococcal meningitis in HIV-positive children.
    Thurey J; Molyneux E
    J Trop Pediatr; 2008 Dec; 54(6):361-3. PubMed ID: 18782859
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV?
    Chimalizeni Y; Tickell D; Connell T
    J Trop Pediatr; 2010 Feb; 56(1):4-12. PubMed ID: 20097705
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prophylaxis for cryptococcal meningitis.
    John L; Nelson M
    HIV Med; 2004 May; 5(3):131-2. PubMed ID: 15139976
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis.
    Cantey PT; Stephens DS; Rimland D
    HIV Med; 2005 Jul; 6(4):253-9. PubMed ID: 16011530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptococcosis in HIV-infected children.
    Likasitwattanakul S; Poneprasert B; Sirisanthana V
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):935-9. PubMed ID: 15916094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B plus fluconazole for HIV-associated cryptococcal meningitis.
    Harrison TS
    Clin Infect Dis; 2009 Jun; 48(12):1784-6. PubMed ID: 19441979
    [No Abstract]   [Full Text] [Related]  

  • 7. Human immunodeficiency virus (HIV) related cryptococcal meningitis in rural central Thailand--treatment difficulties and prevention strategies.
    Wright P; Inverarity D
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):58-61. PubMed ID: 17539247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ending deaths from HIV-related cryptococcal meningitis by 2030.
    Shroufi A; Chiller T; Jordan A; Denning DW; Harrison TS; Govender NP; Loyse A; Baptiste S; Rajasingham R; Boulware DR; Ribeiro I; Jarvis JN; Van Cutsem G
    Lancet Infect Dis; 2021 Jan; 21(1):16-18. PubMed ID: 33271065
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryptococcal disease in HIV infection: treatment and maintenance.
    Fisher M; Price DA; Klein J; Weston R; Coker RJ
    AIDS; 1995 Mar; 9(3):300-1. PubMed ID: 7755921
    [No Abstract]   [Full Text] [Related]  

  • 10. Burden of cryptococcal meningitis in Malawi.
    Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcosis in the developing world: an elephant in the parlor.
    Pappas PG
    Clin Infect Dis; 2010 Feb; 50(3):345-6. PubMed ID: 20038243
    [No Abstract]   [Full Text] [Related]  

  • 12. Free fluconazole for cryptococcal meningitis: too little of a good thing?
    Hamill RJ
    Clin Infect Dis; 2006 Oct; 43(8):1074-6. PubMed ID: 16983623
    [No Abstract]   [Full Text] [Related]  

  • 13. Amphotericin B: the higher the dose, the higher the toxicity.
    Pasqualotto AC
    Clin Infect Dis; 2008 Oct; 47(8):1110; author reply 1110-1. PubMed ID: 18800934
    [No Abstract]   [Full Text] [Related]  

  • 14. [What is reliable in the therapy of cryptococcal meningitis?].
    Glück T; Weber P; Dölle W
    Internist (Berl); 1991 Dec; 32(12):729-31. PubMed ID: 1783515
    [No Abstract]   [Full Text] [Related]  

  • 15. [Questions and answers on cryptococcal meningitis associated with human immunodeficiency virus infection].
    Arribas JR; González-García JJ; Peña JM; Vázquez JJ
    Enferm Infecc Microbiol Clin; 2000 Feb; 18(2):100-3. PubMed ID: 10721591
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
    Seilmaier M; Hecht A; Guggemos W; Rüdisser K
    Med Klin (Munich); 2009 Jan; 104(1):58-62. PubMed ID: 19142596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.
    Martínez E; García-Viejo MA; Marcos MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Miró JM; Gatell JM
    AIDS; 2000 Nov; 14(16):2615-7. PubMed ID: 11101078
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
    Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
    Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial.
    Techapornroong M; Suankratay C
    Scand J Infect Dis; 2007; 39(10):896-901. PubMed ID: 17852947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial commentary: dosing amphotericin B in cryptococcal meningitis.
    Powderly WG
    Clin Infect Dis; 2008 Jul; 47(1):131-2. PubMed ID: 18505386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.